Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Abstract Background Lymphomas are characterized by elevated synthesis of inflammatory soluble mediators that could trigger the development of venous thromboembolism (VTE). However, data on the relationship between specific immune dysregulation and VTE occurrence in patients with lymphoma are scarce....

Full description

Bibliographic Details
Main Authors: Vladimir Otasevic, Biljana Mihaljevic, Natasa Milic, Dejana Stanisavljevic, Vojin Vukovic, Kristina Tomic, Jawed Fareed, Darko Antic
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Thrombosis Journal
Subjects:
Inflammation
Lymphoma
Risk factor
Venous thromboembolism
Anticoagulants
Biomarkers
Online Access:https://doi.org/10.1186/s12959-022-00381-3

Internet

https://doi.org/10.1186/s12959-022-00381-3

Similar Items